Refreshing results…
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review
Download from link.springer.comIFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
UploadMissing publications? Search for publications with a matching author name.